Talk:Liver X receptor

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Figures

I think it will be nice if some one can add in figure showing the location and interaction of players in LXR signaling pathway or LXR protein structure. —The preceding unsigned comment was added by 128.135.148.46 (talk) 18:33, 29 March 2007 (UTC).[reply]

Names shown in the two protein infoboxes

Would it be more informative to give the names LXRα and LXRβ in the two infoboxes, instead of "nuclear receptor subfamily 1, group H, member 3" and "nuclear receptor subfamily 1, group H, member 2"? --Zippy 18:39, 8 May 2007 (UTC)[reply]

Assessment comment

The comment(s) below were originally left at Talk:Liver X receptor/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.

Research of Liver X receptor has become very popular recently becuase several scientists believe that since LXR is important in regulation of cholesterol, fatty acid, glucose and lipid metabolism, the agonists of LXR can be used to treat atherosclerosis, diabetes, and Alzheimer's disease. A few mice experiments support the possibility for clinical application of LXR agonists. Therefore, I think this topic should be important for the public and academic researchers.

Last edited at 17:18, 29 March 2007 (UTC). Substituted at 22:20, 29 April 2016 (UTC)